Research

Energy balance

There are concerns regarding the long-term safety and efficacy of GLP-1 receptor agonists.

Practitioners should monitor patients closely for safety and efficacy when prescribing GLP-1 receptor agonists.

StrongQualifiesmedium confidence
Their use, however, is not without questions and concerns as to long-term safety and efficacy.
Merle Myerson et al. · The Journal of Clinical Pharmacology · 2024

Why this rating

The claim is based on a review of the current state of research.

Source

Pharmacotherapy of Weight‐loss and Obesity with a Focus on GLP 1‐Receptor Agonists

Merle Myerson et al. · The Journal of Clinical Pharmacology · 2024

DOI 10.1002/jcph.2487

reviewCited 17×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →